Back to Companies
Bambusa Therapeutics, Inc.
BBTXNasdaqCIK: 0002044950
Recent Form 4 activity at Bambusa Therapeutics, Inc. (BBTX) spans 14 filings across 9 insiders (all of them on the buy side). Purchases total $58.6M against $0 in sales — heavily weighted toward buying, for a net purchase of $58.6M. RA CAPITAL MANAGEMENT, L.P. is the most active by dollar volume, and the single largest transaction was $46.6M by RA CAPITAL MANAGEMENT, L.P.. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.
Total Volume
$64.7M
Purchases
$58.6M
Sales
$0
Unique Insiders
9
Recent Insider Trades
14 loaded
| Nov 2 | BBTX Bambusa Therapeutics, Inc. | Xu Shanshan | Insider | Conversion | $0 |
| Nov 2 | BBTX Bambusa Therapeutics, Inc. | Salvia Investment GmbH | Insider | Buy | $6.0M |
| Nov 2 | BBTX Bambusa Therapeutics, Inc. | Jeggle Helmut Wolfgang | Insider | Buy | $6.0M |
| Nov 3 | BBTX Bambusa Therapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | Insider | Buy | $46.6M |
| Oct 29 | BBTX Bambusa Therapeutics, Inc. | Ho Minh Quoc Thang | Insider | Other | $0 |
| Nov 2 | BBTX Bambusa Therapeutics, Inc. | Xu Shanshan | Insider | Award | $6.1M |
| Oct 29 | BBTX Bambusa Therapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | Insider | Other | $0 |
| Oct 29 | BBTX Bambusa Therapeutics, Inc. | Liang Howard | Insider | Other | $0 |
| Oct 29 | BBTX Bambusa Therapeutics, Inc. | DiRocco Derek | Insider | Other | $0 |
| Oct 29 | BBTX Bambusa Therapeutics, Inc. | Salvia Investment GmbH | Insider | Other | $0 |
| Oct 29 | BBTX Bambusa Therapeutics, Inc. | Lieber Jonathan I | Insider | Other | $0 |
| Oct 29 | BBTX Bambusa Therapeutics, Inc. | Jeggle Helmut Wolfgang | Insider | Other | $0 |
| Oct 29 | BBTX Bambusa Therapeutics, Inc. | Xu Shanshan | Insider | Other | $0 |
| Oct 29 | BBTX Bambusa Therapeutics, Inc. | Foerster Christian Uwe | Insider | Other | $0 |
14 filings